Creative Medical Technology Holdings (CELZ) Change in Inventory (2020 - 2025)
Creative Medical Technology Holdings (CELZ) posted quarterly Change in Inventory of -$994.0 for Q4 2025, up 17.17% year-over-year from -$848.36 in Q4 2024, and up 17.17% quarter-over-quarter from -$1200.0 in Q1 2025.
Creative Medical Technology Holdings (CELZ) Change in Inventory (2020 - 2025) Analysis & Trends
Creative Medical Technology Holdings (CELZ) has reported Change in Inventory for 6 consecutive years, with -$994.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Change in Inventory rose 17.17% year-over-year to -$994.0; the TTM figure through Mar 2026 stood at -$994.0 (up 82.25% YoY), while the FY2025 annual figure was -$2194.0, up 50.14% from the prior year.
- Change in Inventory climbed to -$994.0 in Q4 2025 per CELZ's latest filing, from -$1200.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $10866.0 in Q4 2021 and bottomed at -$6000.0 in Q4 2023.
- Historically, Change in Inventory has averaged $0.0 across 5 years, with a median of -$1200.0 in 2024.
- Annual changes were most pronounced in 2022 — Change in Inventory slumped 152.46% — and 2023, when it surged 150.73%.
- Creative Medical Technology Holdings' Change in Inventory stood at $10866.0 in 2021, then plunged by 152.46% to -$5700.0 in 2022, then decreased by 5.26% to -$6000.0 in 2023, then soared by 80.0% to -$1200.0 in 2024, then increased by 17.17% to -$994.0 in 2025.
- Business Quant data shows CELZ's Change in Inventory at -$994.0 in Q4 2025, -$1200.0 in Q1 2025, and -$1200.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.93 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.59 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.86 Bn | 53.73 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.42 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.19 Bn | 9.80 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | - |
| 10 | Creative Medical Technology Holdings | 1.84 Mn | 1.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -994.00 |
| Dec 31, 2025 | -994.00 |
| Mar 31, 2025 | -1,200.00 |
| Mar 31, 2025 | -1,200.00 |
| Dec 31, 2024 | -1,200.00 |
| Dec 31, 2024 | -1,200.00 |
| Jun 30, 2024 | -3,200.00 |
| Jun 30, 2024 | -3,200.00 |
| Dec 31, 2023 | -6,000.00 |
| Dec 31, 2023 | -6,000.00 |
| Sep 30, 2023 | 2,400.00 |
| Sep 30, 2023 | 2,400.00 |
| Dec 31, 2022 | -5,700.00 |
| Dec 31, 2022 | -5,700.00 |
| Sep 30, 2022 | -4,731.00 |
| Sep 30, 2022 | -4,731.00 |
| Jun 30, 2022 | 6,475.00 |
| Jun 30, 2022 | 6,475.00 |
| Mar 31, 2022 | 3,284.00 |
| Mar 31, 2022 | 3,284.00 |